Louis C. Lasagna dies

Pathfinder in pharmacology brought rigor to the study of drug effectiveness

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Louis C. Lasagna, MD, best known for having pioneered well controlled research on the placebo effect, died of lymphoma on August 6 at the Newton-Wellesley Hospital in Newton, Mass. Dr. Lasagna was dean emeritus of the Sackler School of Graduate Biomedical Sciences at Tufts University.

"The [placebo] phenomenon was known but [Lasagna's research] was a turning point for how drugs should be evaluated. He was a leading figure in establishing the efficacy of drugs," said David Stollar, acting dean of the Sackler School. "One could be seriously misled in evaluating the effectiveness of a drug without recognizing that some of the effectiveness was not reflecting the action of the drug."

Richard I. Shader, professor of pharmacology and experimental therapeutics at the Sackler School, explained that before Lasagna's studies, "people were just capitalizing on the placebo effect without trying to quantify it. Lou worked with a man named Beecher at Mass ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Milly Dawson

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo